All News
An exciting year and time for GCA and PMR treatment!
- Tocilizumab (IL-6i)
- Secukinumab (IL-17i)
- Sarilumab (IL-6i)
- Mavrilimumab (GM-CSF receptor mAb)
- Tofacitinib (JAKinib)
@RheumNow #RNL2023 https://t.co/d0T2RAssFY
Robert B Chao, MD doctorRBC ( View Tweet)
@RheumNow's review of new drug approvals during 2022 at #RNL2023 https://t.co/IgndlG6lOI
Dr. Rachel Tate uptoTate ( View Tweet)
Extension PEXIVAS study in ANCA vasculitis pts with severe DAH
- no significant effect of PLEX on mortality but do note numerical difference, favoring PLEX in severe DAH
- note difference in curve
@RheumNow #RNL2023 https://t.co/6ktb3Uakw9
Robert B Chao, MD doctorRBC ( View Tweet)
Biosimilars are coming!
Multiple adalimumab biosimilars this year
- will we see a dramatic price difference?
@RheumNow #RNL2023 https://t.co/8vdtXtEGOO
Robert B Chao, MD doctorRBC ( View Tweet)
PMR classification criteria by @anisha_dua @RheumNow #RNL2023
Bursal and biceps tenosynovitis gets one point in PMR classification criteria. https://t.co/Lj1X9mkgBz
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Check out MothertoBaby fact sheets by the NIH and LactRX (by mother to baby) app for pregnancy, disease, and medications. Dr. C. Chambers highlighted this today at #RNL2023 @RheumNow
Dr. Rachel Tate uptoTate ( View Tweet)
Could MTX every other week dosing be an option in patients with stable disease..?
#RNL2023 https://t.co/EZRdQnuXjy
Dr Gurdeep Dulay gurdeep_dulay ( View Tweet)
TYK2 in plaque psoriasis By Eric Ruderman #RNL2023 @RheumNow
Safer?
No lab monitoring
And it works https://t.co/9Woen2q4hZ
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Beautiful summary of GPA management by Dr.Carol Langford #RNL2023 @RheumNow https://t.co/FCwKN9tovX
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
PMR lab studies by @anisha_dua @RheumNow #RNL2023
Majority of patients will have elevated inflammatory markers.
Rapid clinical response to low dose of steroid. https://t.co/AgdIJ5YbOu
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Some points to consider in relapsing PMR , by @anisha_dua @RheumNow #RNL2023
Elevated ESR and CRP rule out GCA.
Relapses are common with steroid tapering, especially below 5mg. https://t.co/D17mdly7z5
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Approach to pregnancy in patients with PsA , By Dr.Chambers #RNL2023 @RheumNow https://t.co/8tSz7qbmQU
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Dr.Robert Spiera approach to GCA #RNL2023 @RheumNow https://t.co/ublzYwBbIF
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
Great #RNL2023 Plenary with "Miracle Larry" after 128 days in hospital for COVID-19, on 3-year anniversary of going into coma
"I am the expert on what this virus can do. I don't want the world to ever forget"
@RheumNow https://t.co/kTuDXDhTtQ
Eric Dein ericdeinmd ( View Tweet)
Tremendously emotional (and unfiltered) first person account of his fight with COVID-19 by Miracle Larry who thanked our Dr. Cush @RheumNow for his ingenuity in fighting COVID-19, thanking healthcare workers for all they do, and reminding us to be empathic.
#RNL2023 https://t.co/i0D7r8dR8n
Robert B Chao, MD doctorRBC ( View Tweet)
Dr. Carol Langford on GPA treatment
Duration of remission maintenance therapy?
- at least 2 years, after 2 years, maintenance appropriate in many cases
- consider RTX, and other cDMARDs (MTX, MMF, AZA)
@RheumNow #RNL2023 https://t.co/VmswcnzN5v
Robert B Chao, MD doctorRBC ( View Tweet)
Sirilumab ( SAPHYR trial) in PMR, By Dr.Robert Spiera #RNL2023 @RheumNow
It also improved patient reported outcomes. Great news👌 https://t.co/NDxhIwvACq
Nouf Al hemmadi NoufAhmedAlham2 ( View Tweet)
#RNL2023
Rob Spiera: I often use aspirin a day, especially if cranial complications and no contra-indications"
No prospective studies, 2 large retrospective studies suggesting benefit
@RheumNow https://t.co/OedVG03yN3
Eric Dein ericdeinmd ( View Tweet)
#RNL2023 Resources for pregnancy and lactation for patients on various #medications and #chronic #diseases. Have a look. Pregnant 🫃 #baby and #breast #feeding. https://t.co/A8zmBUAylG
Janet Pope Janetbirdope ( View Tweet)
I use US in my practice and since this data was presented last year, I’ve been evaluating subacromial/deltoid bursas my PMR patients. @anisha_dua reviews imaging at #RNL2023 @RheumNow https://t.co/1TYdXNmcx0
Dr. Rachel Tate uptoTate ( View Tweet)
